✦ LIBER ✦

Short-term efficacy of the IL6 receptor antibody tocilizumab in patients with HIV-associated multicentric Castleman disease: report of two cases

✍ Scribed by Nagao, Azusa; Nakazawa, Shoko; Hanabusa, Hideji

Book ID: 121566525
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 202 KB
Volume: 7
Category: Article
ISSN: 1756-8722
DOI: 10.1186/1756-8722-7-10

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-interleukin 6 receptor antibody toc

Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease

✍ Kawabata, H.; Tomosugi, N.; Kanda, J.; Tanaka, Y.; Yoshizaki, K.; Uchiyama, T. 📂 Article 📅 2007 🏛 Ferrata Storti Foundation 🌐 Italian ⚖ 228 KB

Down-regulation of hepcidin resulting fr

Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease

✍ Song, S.-N. J.; Tomosugi, N.; Kawabata, H.; Ishikawa, T.; Nishikawa, T.; Yoshiza 📂 Article 📅 2010 🏛 American Society of Hematology 🌐 English ⚖ 306 KB